Evaluation of a Serum Lung Cancer Biomarker Panel.

Conclusions: This study validates the accuracy of a panel of proteins and an autoantibody in a population relevant to lung cancer detection and suggests a benefit to combining clinical features with the biomarker results. PMID: 29371783 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/29371783?dopt=Abstract

Source: Biomarker Insights - January 28, 2018 Category: General Medicine Authors: Mazzone PJ, Wang XF, Han X, Choi H, Seeley M, Scherer R, Doseeva V Tags: Biomark Insights Source Type: research